Partial purification and characterization of a novel antifungal compound against Aspergillus spp. from Synechocystis sp. PCC 6803

Biotechnology and Bioprocess Engineering

Volumn 14, Issue 4, 2009, Pages 383-390

  Yoon, Young Sil ^a   Lee, Choul Gyun ^a  

^a Inha University   (South Korea)

Author keywords

Antifungal; Aspergillosis; Cyanobacteria; Cyclic peptide; Synechocystis sp.

Indexed keywords

ANTIFUNGAL; ASPERGILLOSIS; CYANOBACTERIA; CYCLIC PEPTIDE; SYNECHOCYSTIS SP.;

AMINATION; AMINES; AMINO ACIDS; CELL MEMBRANES; ORGANIC ACIDS; PHENOLS; PHOTODEGRADATION; PURIFICATION; ULTRAVIOLET SPECTROSCOPY;

PEPTIDES;

AK 3; ANTIFUNGAL AGENT; DRUG METABOLITE; ITRACONAZOLE; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS; CONTROLLED STUDY; DEGRADATION; DRUG DETERMINATION; DRUG ISOLATION; DRUG MECHANISM; DRUG PURIFICATION; DRUG SCREENING; DRUG STRUCTURE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; SYNECHOCYSTIS; ULTRAVIOLET SPECTROSCOPY;

ASPERGILLUS; CYANOBACTERIA; FUNGI; SYNECHOCYSTIS SP.; SYNECHOCYSTIS SP. PCC 6803;

EID: 70349651181     PISSN: 12268372     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12257-009-0082-3     Document Type: Article

References (31)

1. Niimi, M., Y. Nagai, K. Niimi, S. Wada, R. D. Cannon, Y. Uehara, and B. C. Monk (2002) Identification of two proteins induced by exposure of the pathogenic fungus Candida glabrata to fluconazole. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 782: 245-252.
2. Chamilos, G., M. S. Lionakis, R. E. Lewis, and P. Kontoyiannis (2007) Role of mini-host models in the study of medically important fungi. Lancet Infec. Dis. 7: 42-55.
3. Denning, D. W. (1998) Invasive aspergillosis. Clin. Infect. Dis. 26: 781-803.
4. Latge, J. P. (2001) The pathobiology of Aspergillus fumigatus. Trends Microbiol. 9: 382-389.
5. Rodrigues, A. G., R. Araujo, and C. Pina-Vaz (2006) Interaction of local anaesthetics with other antifungal agents against pathogenic Aspergillus. Int. J. Antimicrob. Agents 27: 339-343.
6. Alberti, C., A. Bouakline, P. Ribaud, C. Lacroix, P. Rousselot, T. Leblanc, and F. Derouin (2001) Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients. J. Hosp. Infect. 48: 198-206.
7. Perfect, J. R., G. M. Cox, J. Y. Lee, C. A. Kauffman, L. De Repentigny, S. W. Chapman, V. A. Morrison, P. Pappas, J. W. Hiemenz, and D. A. Stevens (2001) The impact of culture isolation of Aspergillus species: A hospital-based survey of aspergillosis. Clin. Infect. Dis. 33: 1824-1833.
8. Wald, A., W. Leisenring, J. A. vanBurik, and R. A. Bowden (1997) Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J. Infect. Dis. 175: 1459-1466.
9. Burja, A. M., B. Banaigs, E. Abou-Mansour, J. G. Burgess, and P. C. Wright (2001) Marine cyanobacteria: A prolific source of natural products. Tetrahedron 57: 9347-9377.
10. Park, H. D., M. F. Watanabe, K. I. Harada, M. Suzuki, H. Hayashi, and T. Okino (1993) Seasonal variations of Microcystis species and toxic heptapeptide microcystins in lake Suwa. Environ. Toxicol. Water Qual. 8: 425-435.
11. Kreitlow, S., S. Mundt, and U. Lindequist (1999) Cyanobacteria: A potential source of new biologically active substances. J. Biotechnol. 70: 61-63.
12. Nagle, D. G. and V. J. Paul (1999) Production of secondary metabolites by filamentous tropical marine cyanobacteria: Ecological functions of the compounds. J. Phycol. 35: 1412-1421.
13. Mundt, S., S. Kreitlow, A. Nowotny, and U. Effmert (2001) Biochemical and pharmacological investigations of selected cyanobacteria. Int. J. Hyg. Environ. Health 203: 327-334.
14. Rinehart, K. L., M. Namikoshi, and B. W. Choi (1994) Structure and biosynthesis of toxins from blue-green algae (cyanobacteria). J. Appl. Phycol. 6: 159-176.
15. Hong, S.-J. and C.-G. Lee (2008) Statistical optimization of culture media for production of phycobiliprotein by Synechocystis sp. PCC 6701. Biotechnol. Bioprocess Eng. 13: 491-498.
16. Codd, G. A. (1995) Cyanobacterial toxins: Occurrence, properties, and biological significance. Water Sci. Technol. 32: 149-156.
17. Li, Z. L., T. M. Bricker, and R. Burnap (2000) Kinetic characterization of his-tagged CP47 Photosystem II in Synechocystis sp PCC6803. Biochim. Biophys. Acta. Bioenerg. 1460: 384-389.
18. Van Thor, J. J., R. Jeanjean, M. Havaux, K. A. Sjollema, F. Joset, K. J. Hellingwerf, and H. C. P. Matthijs (2000) Salt shock-inducible photosystem I cyclic electron transfer in Synechocystis PCC6803 relies on binding of ferredoxin: NADP(+) reductase to the thylakoid membranes via its CpcD phycobilisome-linker homologous N-terminal domain. Biochim. Biophys. Acta. Bioenerg. 1457: 129-144.
19. Kaneko, T., S. Sato, H. Kotani, A. Tanaka, E. Asamizu, Y. Nakamura, N. Miyajima, M. Hirosawa, M. Sugiura, S. Sasamoto, T. Kimura, T. Hosouchi, A. Matsuno, A. Muraki, N. Nakazaki, K. Naruo, S. Okumura, S. Shimpo, C. Takeuchi, T. Wada, A. Watanabe, M. Yamada, M. Yasuda, and S. Tabata (1996) Sequence analysis of the genome of the unicellular cyanobacterium Synechocystis sp. strain PCC 6803. II: Sequence determination of the entire genome and assignment of potential proteincoding regions. DNA Res. 3: 109-136.
20. Hong, S.-J. and C.-G. Lee (2007) Evaluation of central metabolism based on a genomic database of Synechocystis PCC6803. Biotechnol. Bioprocess Eng. 12: 165-173.
21. De Castillo, M. C., O. A. De Saab, O. M. De Nader, and A. P. D. Holgado (1997) Evaluation of the standardized disk diffusion and agar dilution antibiotic susceptibility test methods by using strains of Neisseria gonorrhoeae from Tucuman, Argentina. Biol. Pharm. Bull. 20: 1010-1012.
22. Fujii, K., K. Sivonen, E. Naganawa, and K. Harada (2000) Non-toxic peptides from toxic cyanobacteria, Oscillatoria agardhii. Tetrahedron 56: 725-733.
23. Lawton, L. A., C. Edwards, and G. A. Codd (1994) Extraction and high-performance liquid chromatographic method for the determination of microcystins in raw and treated waters. The Analyst 119: 1525-1530.
24. Campinas, M. and M. J. Rosa (2006) The ionic strength effect on microcystin and natural organic matter surrogate adsorption onto PAC. J. Colloid Interf. Sci. 299: 520-529.
25. Weiss, J., H. P. Liebert, and W. Braune (2000) Influence of microcystin-RR on growth and photosynthetic capacity of the duckweed Lemna minor L. J. Appl. Bot. 74: 100-105.
26. Gromov, B. V., A. A. Vepritskiy, N. N. Titova, K. A. Mamkaeyeva, and O. V. Alexandrova (1991) Production of the antibiotic cyanobacterin LU-1 by Nostoc linckia CALU 892. J. Appl. Phycol. 3: 55-79.
27. Georgopapadakou, N. H. and T. J. Walsh (1996) Antifungal agents: Chemotherapeutic targets and immunologic strategies. Antimicrob. Agents Chemother. 40: 279-291.
28. Jamison, J., S. Levy, X. C. Sun, D. Zeckner, W. Current, M. Zweifel, M. Rodriguez, W. Turner, and S. H. Chen (2000) Syntheses and antifungal activity of pseudomycin side-chain analogues. Part 1. Bioorg. Med. Chem. Lett. 10: 2101-2105.
29. Papayannopoulos, I. A. (1995) The interpretation of collision-induced dissociation tandem mass spectra of peptides. Mass Spec. Rev. 14: 49-73.
30. Murakami, M., H. J. Shin, H. Matsuda, K. Ishida, and K. Yamaguchi (1997) A cyclic peptide, anabaenopeptin B, from the cyanobacterium Oscillatoria agardhii. Phytochemistry 44: 449-452.
31. Kajiyama, S., H. Kanzaki, K. Kawazu, and A. Kobayashi (1998) Nostofungicidine, an antifungal lipopeptide from the field-grown terrestrial blue-green alga Nostoc commune. Tetrahedron Lett. 39: 3737-3740.